AR041360A1 - Proceso para la preparacion de valsartan - Google Patents
Proceso para la preparacion de valsartanInfo
- Publication number
- AR041360A1 AR041360A1 ARP030103458A ARP030103458A AR041360A1 AR 041360 A1 AR041360 A1 AR 041360A1 AR P030103458 A ARP030103458 A AR P030103458A AR P030103458 A ARP030103458 A AR P030103458A AR 041360 A1 AR041360 A1 AR 041360A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- salt
- compound
- resulting
- convert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La presente se refiere a un proceso para la fabricación de un bloqueador del receptor de angiotensina (ARB; también denominado antagonista del receptor de angiotensina II ó antagonista del receptor AT1), y sales del mismo, a intermediarios, y a lospasos del proceso. Reivindicación 1: Un proceso para la fabricación del compuesto de la fórmula (1), o una sal del mismo, el cual comprende: a) hacer reaccionar un compuesto de la fórmula (2), o una sal del mismo, en donde R1 es hidrógeno o ungrupo protector de tetrazol, con un compuesto de la fórmula (3) o quiral, o una sal del mismo, en donde R2 representa hidrógeno o un grupo protector de carboxilo, bajo las condiciones de una aminación reductiva; y b) acilar un compuesto resultantede la fórmula (4) o quiral, o una sal del mismo, con un compuesto de la fórmula (5), en donde R3 es un grupo activador; y c) si R1 y/o R2 son diferentes de hidrógeno, remover los grupos protectores en un compuesto resultante de la fórmula (6) oquiral, o una sal del mismo; y d) aislar un compuesto resultante de la fórmula (1) o una sal del mismo; y si se desea, convertir un ácido libre resultante de la fórmula (1) en una sal del mismo, o convertir una sal resultante de un compuesto de lafórmula (1) en el ácido libre de la fórmula (1), o convertir una sal resultante de un compuesto de la fórmula (1) en una sal diferente.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0222056.4A GB0222056D0 (en) | 2002-09-23 | 2002-09-23 | Process for the manufacture of organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR041360A1 true AR041360A1 (es) | 2005-05-11 |
Family
ID=9944606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP030103458A AR041360A1 (es) | 2002-09-23 | 2003-09-23 | Proceso para la preparacion de valsartan |
Country Status (30)
| Country | Link |
|---|---|
| US (3) | US20060069268A1 (es) |
| EP (2) | EP1878729A1 (es) |
| JP (2) | JP4787498B2 (es) |
| KR (2) | KR20050057529A (es) |
| CN (2) | CN100357279C (es) |
| AR (1) | AR041360A1 (es) |
| AU (1) | AU2003270241B2 (es) |
| BR (1) | BR0314132A (es) |
| CA (1) | CA2502629A1 (es) |
| CY (1) | CY1107878T1 (es) |
| DE (1) | DE60317690T2 (es) |
| DK (1) | DK1546122T3 (es) |
| EC (2) | ECSP055695A (es) |
| ES (1) | ES2295623T3 (es) |
| GB (1) | GB0222056D0 (es) |
| HK (1) | HK1079771A1 (es) |
| IL (1) | IL167426A (es) |
| MX (1) | MXPA05003140A (es) |
| MY (1) | MY138618A (es) |
| NO (2) | NO20051970L (es) |
| NZ (2) | NZ566863A (es) |
| PE (2) | PE20091387A1 (es) |
| PL (1) | PL374862A1 (es) |
| PT (1) | PT1546122E (es) |
| RU (2) | RU2348619C2 (es) |
| SG (1) | SG155049A1 (es) |
| SI (1) | SI1546122T1 (es) |
| TW (2) | TWI329106B (es) |
| WO (1) | WO2004026847A1 (es) |
| ZA (1) | ZA200502159B (es) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1511739B1 (en) * | 2003-03-17 | 2008-04-30 | Teva Pharmaceutical Industries Ltd. | Polymorphs of valsartan |
| US7199144B2 (en) | 2003-04-21 | 2007-04-03 | Teva Pharmaceuticals Industries, Ltd. | Process for the preparation of valsartan and intermediates thereof |
| EP1556363A2 (en) * | 2003-04-21 | 2005-07-27 | Teva Pharmaceutical Industries Limited | Process for the preparation of valsartan and intermediates thereof |
| US7378531B2 (en) | 2003-04-21 | 2008-05-27 | Teva Pharmaceutical Industries Ltd | Process for the preparation of valsartan |
| GB0316546D0 (en) | 2003-07-15 | 2003-08-20 | Novartis Ag | Process for the manufacture of organic compounds |
| GB0402262D0 (en) * | 2004-02-02 | 2004-03-10 | Novartis Ag | Process for the manufacture of organic compounds |
| EP1661891A1 (en) * | 2004-11-30 | 2006-05-31 | KRKA, D.D., Novo Mesto | A process for the synthesis of valsartan |
| GB0514206D0 (en) | 2005-07-11 | 2005-08-17 | Novartis Ag | Organic compounds |
| ES2288376B1 (es) * | 2005-10-20 | 2008-11-01 | Inke, S.A. | Procedimiento para la obtencion de intermedios utiles en la obtencion de un compuesto farmaceuticamente activo. |
| WO2007057919A2 (en) * | 2005-10-25 | 2007-05-24 | Alembic Limited | An improved process for preparation of (s)-n-(1-carboxy-2-methyl-prop-1-yl)-n-pentanoyl-n-[2'-(1h-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine |
| EP2057132A2 (en) * | 2006-07-03 | 2009-05-13 | Aurobindo Pharma Limited | Process for the preparation of the angiotensin ii antagonist valsartan |
| ES2315141B1 (es) * | 2006-11-23 | 2009-12-22 | Quimica Sintetica, S.A | Procedimiento para la preparacion de cardesartan cilexetilo en forma cristalina. |
| CN101200455B (zh) * | 2007-09-29 | 2010-08-18 | 泰兴市江神化工有限公司 | 沙坦类治疗高血压药物主环5-(4'-甲酰基联苯-2-基)-1h-四氮唑的制备方法 |
| US7943794B2 (en) * | 2008-02-13 | 2011-05-17 | Ranbaxy Laboratories Limited | Processes for the preparation of intermediates of valsartan |
| KR101012135B1 (ko) * | 2008-12-18 | 2011-02-07 | 주식회사 대희화학 | 발사르탄 메틸 에스테르의 제조방법 |
| EP2316821A1 (en) | 2009-10-27 | 2011-05-04 | Novartis AG | Process for the manufacture of organic compounds |
| CA2806657A1 (en) * | 2010-08-03 | 2012-02-09 | Novartis Ag | Highly crystalline valsartan |
| CN102351804B (zh) * | 2011-09-30 | 2013-07-31 | 浙江新赛科药业有限公司 | 一种缬沙坦消旋体的回收方法 |
| CN103554047A (zh) * | 2013-10-11 | 2014-02-05 | 镇江市高等专科学校 | 制备缬沙坦的方法 |
| CN103923028B (zh) * | 2014-05-04 | 2017-05-24 | 青岛雪洁助剂有限公司 | 一种缬沙坦甲酯的制备方法 |
| CN104072433A (zh) * | 2014-07-16 | 2014-10-01 | 南京正大天晴制药有限公司 | 一种缬沙坦的水解杂质化合物及其制备方法、检测方法和用途 |
| CN104151199A (zh) * | 2014-08-13 | 2014-11-19 | 苏州卫生职业技术学院 | 一种缬沙坦的合成方法 |
| CN104844476B (zh) * | 2015-04-03 | 2016-08-24 | 李凌 | 一种医药中间体联苯类化合物的合成方法 |
| CN112014479A (zh) * | 2019-05-28 | 2020-12-01 | 珠海润都制药股份有限公司 | 一种缬沙坦中正戊酰氯的检测方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0443983B1 (de) * | 1990-02-19 | 1996-02-28 | Ciba-Geigy Ag | Acylverbindungen |
| US5260325A (en) * | 1991-08-19 | 1993-11-09 | E. I. Du Pont De Nemours And Company | Angiotensin II receptor blocking tertiary amides |
| EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
| FR2688503B1 (fr) * | 1992-03-16 | 1994-05-06 | Synthelabo | Procede de preparation de derives de 2-(tetrazol-5-yl)-[1,1'-biphenyle]. |
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| JPH08165292A (ja) * | 1993-10-07 | 1996-06-25 | Techno Res Kk | アデニン誘導体、その製造法及び用途 |
| US5468867A (en) * | 1994-05-27 | 1995-11-21 | Syntex (U.S.A.) Inc. | Process for preparing1-butyl-2-[2'-(2H-tetrazol-5-yl)biphenyl-4-ylmethyl1-1H-indole-3-carboxylic acid |
| US5412102A (en) * | 1994-05-27 | 1995-05-02 | Syntex (U.S.A.) Inc. | Processes for preparing 1-butyl-2-[2'-(2H-tetrazol-5-yl) biphenyl-4-ylmethyl]-1H-indole-3-carboxylic acid |
| WO1996009301A1 (fr) * | 1994-09-20 | 1996-03-28 | Wakunaga Seiyaku Kabushiki Kaisha | Procede de production d'un derive de n-biphenylmethylthiadiazoline ou un sel de celui-ci et son intermediaire de production |
| BR9609403A (pt) * | 1995-06-07 | 1999-05-11 | American Home Prod | Processo para a preparação de derivados de bifenila |
| CN1137887C (zh) * | 2000-04-07 | 2004-02-11 | 常州四药制药有限公司 | 一种合成缬沙坦的改进方法 |
| CN1216873C (zh) * | 2000-07-19 | 2005-08-31 | 诺瓦提斯公司 | 缬沙坦的盐 |
| GB0402262D0 (en) * | 2004-02-02 | 2004-03-10 | Novartis Ag | Process for the manufacture of organic compounds |
-
2002
- 2002-09-23 GB GBGB0222056.4A patent/GB0222056D0/en not_active Ceased
-
2003
- 2003-09-22 WO PCT/EP2003/010543 patent/WO2004026847A1/en active Application Filing
- 2003-09-22 SG SG200702272-6A patent/SG155049A1/en unknown
- 2003-09-22 RU RU2005112444/04A patent/RU2348619C2/ru not_active IP Right Cessation
- 2003-09-22 PT PT03750599T patent/PT1546122E/pt unknown
- 2003-09-22 MY MYPI20033603A patent/MY138618A/en unknown
- 2003-09-22 AU AU2003270241A patent/AU2003270241B2/en not_active Ceased
- 2003-09-22 SI SI200331125T patent/SI1546122T1/sl unknown
- 2003-09-22 TW TW092126088A patent/TWI329106B/zh not_active IP Right Cessation
- 2003-09-22 CN CNB038245140A patent/CN100357279C/zh not_active Expired - Fee Related
- 2003-09-22 MX MXPA05003140A patent/MXPA05003140A/es active IP Right Grant
- 2003-09-22 NZ NZ566863A patent/NZ566863A/en not_active IP Right Cessation
- 2003-09-22 CN CN2007101692527A patent/CN101153027B/zh not_active Expired - Fee Related
- 2003-09-22 KR KR1020057004873A patent/KR20050057529A/ko not_active Application Discontinuation
- 2003-09-22 JP JP2004537146A patent/JP4787498B2/ja not_active Expired - Fee Related
- 2003-09-22 DE DE60317690T patent/DE60317690T2/de not_active Expired - Lifetime
- 2003-09-22 DK DK03750599T patent/DK1546122T3/da active
- 2003-09-22 ES ES03750599T patent/ES2295623T3/es not_active Expired - Lifetime
- 2003-09-22 CA CA002502629A patent/CA2502629A1/en not_active Abandoned
- 2003-09-22 RU RU2008133680/04A patent/RU2412173C2/ru not_active IP Right Cessation
- 2003-09-22 EP EP07113176A patent/EP1878729A1/en not_active Withdrawn
- 2003-09-22 EP EP03750599A patent/EP1546122B8/en not_active Revoked
- 2003-09-22 TW TW098146486A patent/TWI338003B/zh not_active IP Right Cessation
- 2003-09-22 BR BR0314132-2A patent/BR0314132A/pt not_active IP Right Cessation
- 2003-09-22 US US10/528,323 patent/US20060069268A1/en not_active Abandoned
- 2003-09-22 NZ NZ538927A patent/NZ538927A/en not_active IP Right Cessation
- 2003-09-22 KR KR1020117002725A patent/KR20110015703A/ko not_active Application Discontinuation
- 2003-09-22 PL PL03374862A patent/PL374862A1/xx not_active Application Discontinuation
- 2003-09-23 PE PE2008001800A patent/PE20091387A1/es not_active Application Discontinuation
- 2003-09-23 AR ARP030103458A patent/AR041360A1/es unknown
- 2003-09-23 PE PE2003000976A patent/PE20050088A1/es not_active Application Discontinuation
-
2005
- 2005-03-14 IL IL167426A patent/IL167426A/en not_active IP Right Cessation
- 2005-03-15 ZA ZA200502159A patent/ZA200502159B/en unknown
- 2005-03-21 EC EC2005005695A patent/ECSP055695A/es unknown
- 2005-04-22 NO NO20051970A patent/NO20051970L/no not_active Application Discontinuation
- 2005-12-20 HK HK05111768A patent/HK1079771A1/xx not_active IP Right Cessation
-
2008
- 2008-02-04 CY CY20081100145T patent/CY1107878T1/el unknown
- 2008-12-23 US US12/317,426 patent/US20090111995A1/en not_active Abandoned
-
2010
- 2010-02-11 EC EC2010005695A patent/ECSP105695A/es unknown
- 2010-06-15 US US12/815,704 patent/US20100249429A1/en not_active Abandoned
- 2010-08-02 JP JP2010173583A patent/JP2010254709A/ja active Pending
-
2011
- 2011-06-15 NO NO20110856A patent/NO20110856L/no not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR041360A1 (es) | Proceso para la preparacion de valsartan | |
| PE20070808A1 (es) | COMPUESTOS DERIVADOS DE ISOQUINOLINA COMO INHIBIDORES DE Rho-QUINASA | |
| NO20064200L (no) | Fremgangsmate for syntese av en CXCR4-antagonist | |
| AR061667A1 (es) | Arilamidas sustituidas con tetrazol | |
| BRPI0507312A (pt) | derivados de quinolina para uso como inibidores micobacterianos | |
| JP2015525215A5 (es) | ||
| AR047746A1 (es) | Un procedimiento para la sintesis del (1s)-4,5-dimetoxi-1-(metilaminometil)-benzo-ciclobutano y sus sales de adicion, un metodo para la resolucion de su intermediario de sintesis racemico y su aplicacion a la sintesis de la ivabradina y sus sales de adicion con un acido farmaceuticamente aceptable | |
| PE20070141A1 (es) | Derivados de isoquinolina como inhibidores de rho-cinasa | |
| MX2009004910A (es) | Compuestos sustituidos de 3-isobutil-9,10-dimetoxi-1,3,4,6,7,11-b- hexahidro-2h-pirido[2,1-a] isoquinolin-2-ol y métodos que se relacionan al mismo. | |
| BRPI0500585A (pt) | Processo para a sìntese de ivabradina e sais de adição desta com um ácido farmaceuticamente aceitável | |
| NO20063748L (no) | Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer | |
| CL2009002201A1 (es) | Procedimiento de sintesis de ivabradina por aminacion reductiva y posterior resolucion optica; y uno de los compuestos intermediarios considerados. | |
| UA108378C2 (uk) | Спосіб одержання плеуромутилінів | |
| NI201000049A (es) | Método para producir 2'-desoxi-5-azacitidina (decitabina) | |
| MA31325B1 (fr) | Nouveaux procedes | |
| AR040473A1 (es) | Derivados de aminoalcoholes, un procedimiento de preparacion, composicion farmaceutica y uso del compuesto para preparar medicamentos | |
| PE20091359A1 (es) | Proceso de preparacion de compuestos organicos intermediarios de inhibidores de renina | |
| CO6290756A2 (es) | Proceso para la preparacion de 6-sustituido -1-(2h)-isoquinolinonas | |
| RU2009122481A (ru) | Эффективный способ получения соединений мугеиновой кислоты | |
| AR079294A1 (es) | Acidos homoglutamico y acidos glutamico marcados con yodo y metodo de preparacion de los mismos | |
| NO20051867L (no) | Fremgangsmate for fremstilling av intermediater | |
| CY1112979T1 (el) | Διαδικασια για την παρασκευη της ενωσης (s)-1-αλκυλ-2',6'-πιπεκολοξυλιδιδιου | |
| EA200700198A1 (ru) | Получение гидрохлоридов производного тетразола | |
| CN101948418B (zh) | 含羟脯氨酸结构的hiv-1蛋白酶抑制剂及其制备方法与应用 | |
| AR045517A1 (es) | Procedimiento para la sintesis de perindopril y de sus sales farmaceuticamente aceptables |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |